Literature DB >> 23280834

Amyotrophic lateral sclerosis and organ donation: is there risk of disease transmission?

Brandon B Holmes1, Marc I Diamond.   

Abstract

A new protocol suggests that patients with amyotrophic lateral sclerosis (ALS) are a viable source of tissue for organ transplantation. However, multiple lines of evidence suggest that many neurodegenerative diseases, including ALS, might progress due to transcellular propagation of protein aggregation among neurons. Transmission of the disease state from donor to host thus may be possible under the permissive circumstances of graft transplantation. We argue for careful patient selection and close longitudinal follow-up of recipients when harvesting organs from individuals with neurodegenerative disease, especially dominantly inherited forms.
Copyright © 2012 American Neurological Association.

Entities:  

Mesh:

Year:  2012        PMID: 23280834      PMCID: PMC3569489          DOI: 10.1002/ana.23684

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  57 in total

Review 1.  Shattuck lecture--neurodegenerative diseases and prions.

Authors:  S B Prusiner
Journal:  N Engl J Med       Date:  2001-05-17       Impact factor: 91.245

2.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

3.  Prion-like acceleration of a synucleinopathy in a transgenic mouse model.

Authors:  Anne-Laure Mougenot; Simon Nicot; Anna Bencsik; Eric Morignat; Jérémy Verchère; Latefa Lakhdar; Stéphane Legastelois; Thierry Baron
Journal:  Neurobiol Aging       Date:  2011-08-03       Impact factor: 4.673

4.  Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease.

Authors:  P Duffy; J Wolf; G Collins; A G DeVoe; B Streeten; D Cowen
Journal:  N Engl J Med       Date:  1974-03-21       Impact factor: 91.245

5.  Some speculations about prions, amyloid, and Alzheimer's disease.

Authors:  S B Prusiner
Journal:  N Engl J Med       Date:  1984-03-08       Impact factor: 91.245

6.  Trans-cellular propagation of Tau aggregation by fibrillar species.

Authors:  Najla Kfoury; Brandon B Holmes; Hong Jiang; David M Holtzman; Marc I Diamond
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

Review 7.  Iatrogenic Creutzfeldt-Jakob disease at the millennium.

Authors:  P Brown; M Preece; J P Brandel; T Sato; L McShane; I Zerr; A Fletcher; R G Will; M Pocchiari; N R Cashman; J H d'Aignaux; L Cervenáková; J Fradkin; L B Schonberger; S J Collins
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

8.  High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation.

Authors:  Jiou Wang; Guilian Xu; David R Borchelt
Journal:  Neurobiol Dis       Date:  2002-03       Impact factor: 5.996

Review 9.  Recent advances in the genetics of the ALS-FTLD complex.

Authors:  Huw R Morris; Adrian J Waite; Nigel M Williams; James W Neal; Derek J Blake
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

10.  Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice.

Authors:  Kelvin C Luk; Victoria M Kehm; Bin Zhang; Patrick O'Brien; John Q Trojanowski; Virginia M Y Lee
Journal:  J Exp Med       Date:  2012-04-16       Impact factor: 14.307

View more
  9 in total

1.  Deceased organ and tissue donation after medical assistance in dying and other conscious and competent donors: guidance for policy.

Authors:  James Downar; Sam D Shemie; Clay Gillrie; Marie-Chantal Fortin; Amber Appleby; Daniel Z Buchman; Christen Shoesmith; Aviva Goldberg; Vanessa Gruben; Jehan Lalani; Dirk Ysebaert; Lindsay Wilson; Michael D Sharpe
Journal:  CMAJ       Date:  2019-06-03       Impact factor: 8.262

2.  Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone.

Authors:  David J Irwin; Joseph Y Abrams; Lawrence B Schonberger; Ellen Werber Leschek; James L Mills; Virginia M-Y Lee; John Q Trojanowski
Journal:  JAMA Neurol       Date:  2013-04       Impact factor: 18.302

Review 3.  Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis.

Authors:  S Bräuer; V Zimyanin; A Hermann
Journal:  J Neural Transm (Vienna)       Date:  2018-02-08       Impact factor: 3.575

Review 4.  Biology and genetics of prions causing neurodegeneration.

Authors:  Stanley B Prusiner
Journal:  Annu Rev Genet       Date:  2013       Impact factor: 16.830

Review 5.  A seeded propagation of Cu, Zn-superoxide dismutase aggregates in amyotrophic lateral sclerosis.

Authors:  Mariko Ogawa; Yoshiaki Furukawa
Journal:  Front Cell Neurosci       Date:  2014-03-18       Impact factor: 5.505

Review 6.  Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration.

Authors:  Carlo Scialò; Elena De Cecco; Paolo Manganotti; Giuseppe Legname
Journal:  Viruses       Date:  2019-03-14       Impact factor: 5.048

7.  On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases.

Authors:  Giuseppe Legname; Carlo Scialò
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

8.  Tau: A Common Denominator and Therapeutic Target for Neurodegenerative Disorders.

Authors:  Alexander Maxan; Francesca Cicchetti
Journal:  J Exp Neurosci       Date:  2018-05-01

9.  Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology.

Authors:  Marie Rieux; Melanie Alpaugh; Giacomo Sciacca; Martine Saint-Pierre; Maria Masnata; Hélèna L Denis; Sébastien A Lévesque; Frank Herrmann; Chantal Bazenet; Alexandre P Garneau; Paul Isenring; Ray Truant; Abid Oueslati; Peter V Gould; Anne Ast; Erich E Wanker; Steve Lacroix; Francesca Cicchetti
Journal:  Mol Psychiatry       Date:  2020-06-08       Impact factor: 15.992

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.